Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4',5,7-trihydroxyflavanone
2. Be 14348a
3. Be-14348a
4. Naringenin-7-sulfate
1. 480-41-1
2. Salipurpol
3. Salipurol
4. (s)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
5. (s)-naringenin
6. Pelargidanon
7. (2s)-naringenin
8. Naringetol
9. Naringenine
10. Asahina
11. Nsc 11855
12. Ccris 5839
13. (-)-naringenin
14. Yso1
15. Nsc 34875
16. (-)-(2s)-naringenin
17. Chembl9352
18. (s)-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
19. Ai3-23355
20. Hn5425sbf2
21. Chebi:17846
22. Flavanone, 4',5,7-trihydroxy-
23. 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
24. 4h-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2s)-
25. Narigenin
26. Nsc-11855
27. (2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4h-chromen-4-one
28. 5,7,4'-trihydroxyflavanone
29. (r,s)-naringenin
30. Sr-01000721771
31. (2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
32. Unii-hn5425sbf2
33. 2uxu
34. 4deu
35. S-dihydrogenistein
36. Einecs 207-550-2
37. Pelargidanon 1602
38. Spectrum_000247
39. 4eh3
40. Naringenin [mi]
41. Spectrum2_000325
42. Spectrum3_000567
43. Spectrum4_000124
44. Spectrum5_001423
45. Naringenin [inci]
46. 4',5,7-trioh-flavone
47. 4',5,7-trihydroxyflavanon
48. Naringenin, (-)-
49. Schembl20570
50. Bspbio_001954
51. Kbiogr_000508
52. Kbioss_000727
53. Mls000574861
54. Bidd:er0116
55. Divk1c_000118
56. Spectrum1500746
57. Spbio_000329
58. 4',5, 7-trihydroxyflavanone
59. 5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4h-chromen-4-one
60. Dtxsid1022392
61. Bdbm23419
62. Hms500f20
63. Kbio1_000118
64. Kbio2_000727
65. Kbio2_003295
66. Kbio2_005863
67. Kbio3_001454
68. 4h-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (s)-
69. Ninds_000118
70. (2s)-5,7,4'-trihydroxyflavone
71. Aids001417
72. Hms2202m06
73. Zinc156701
74. (2s)-4',5,7-trihydroxyflavanone
75. Hy-n0100
76. Tnp00287
77. (2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one
78. (s)-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone
79. Ccg-38601
80. Lmpk12140001
81. Phytochemistry 8: 127 (1969)
82. S2394
83. (2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-one
84. Akos016843490
85. Cs-6421
86. Db03467
87. Fs-4072
88. Sdccgmls-0066570.p001
89. (2s)-4',5,7-trihydroxyflavan-4-one
90. Idi1_000118
91. Ncgc00016457-01
92. Ncgc00016457-02
93. Ncgc00016457-03
94. Ncgc00017346-01
95. Ncgc00163598-01
96. Ac-33954
97. Cas-480-41-1
98. Flavanone, 4',5,7-trihydroxy- (8ci)
99. Smr000156272
100. Ft-0617134
101. Sw219329-1
102. C00509
103. A827427
104. Q418374
105. Q-100666
106. Sr-01000721771-3
107. Sr-01000721771-4
108. 5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-chroman-4-one
109. Brd-k08832567-001-02-4
110. Brd-k08832567-001-06-5
111. (-)-(2s)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
112. (s)-2,3-dihydo-5,7-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
113. 2,3-dihydro-5,6-dihydroxy-2-(4-hydroxyphenyl)-4h-1-benzopyran-4-one
114. 4h-1-benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2s)-
115. 13308-00-4
Molecular Weight | 272.25 g/mol |
---|---|
Molecular Formula | C15H12O5 |
XLogP3 | 2.4 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 1 |
Exact Mass | 272.06847348 g/mol |
Monoisotopic Mass | 272.06847348 g/mol |
Topological Polar Surface Area | 87 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 363 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Estrogen Antagonists
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?